Audit 47750

FY End
2022-06-30
Total Expended
$40.60M
Findings
0
Programs
26
Year: 2022 Accepted: 2022-12-21

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.839 Blood Diseases and Resources Research $1.19M Yes 0
93.867 Vision Research $859,472 Yes 0
93.838 Lung Diseases Research $830,004 Yes 0
99.999 Office of Personnel Management $626,904 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $413,658 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $286,789 Yes 0
93.859 Biomedical Research and Research Training $270,631 Yes 0
93.865 Child Health and Human Development Extramural Research $264,839 Yes 0
93.396 Cancer Biology Research $245,157 Yes 0
47.074 Biological Sciences $225,567 Yes 0
93.498 Provider Relief Fund $194,356 - 0
93.213 Research and Training in Complementary and Integrative Health $126,682 Yes 0
93.350 National Center for Advancing Translational Sciences $117,019 Yes 0
93.310 Trans-Nih Research Support $116,559 Yes 0
93.172 Human Genome Research $92,186 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $76,912 Yes 0
93.121 Oral Diseases and Disorders Research $53,143 Yes 0
93.855 Allergy, Immunology and Transplantation Research $31,812 Yes 0
93.393 Cancer Cause and Prevention Research $19,946 Yes 0
93.837 Cardiovascular Diseases Research $13,516 Yes 0
93.394 Cancer Detection and Diagnosis Research $11,713 Yes 0
21.019 Coronavirus Relief Fund $7,120 - 0
93.866 Aging Research $2,241 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $1,751 Yes 0
93.279 Drug Abuse and Addiction Research Programs $634 Yes 0
12.420 Military Medical Research and Development $27 Yes 0

Contacts

Name Title Type
NGCNCJ1X6XA4 Tim Hassen Auditee
4052717452 Tom Knight Auditor
No contacts on file

Notes to SEFA

Accounting Policies: 1.The purpose of the Schedule of Expenditures of Federal Awards (the Schedule) is to present a summary of the activities of Oklahoma Medical Research Foundation (the Foundation) for the year ended June 30, 2022, which have been financed by the U.S. Government.For purposes of the schedule, federal awards have been classified into two types:?Direct federal awards consisting of federal assistance; and?Pass-through funds received from non-federal organizations made under federally sponsored programs conducted by those organizations.The Schedule is prepared on the cash basis of accounting. Expenditures are recognized when paid.Federal awards provided to subrecipient are treated as expenditures when they are paid to the subrecipient.2.Assistance Listing Numbers (ALN) are presented for those programs for which such numbers were available.3.Federal direct programs are presented by federal department and, where applicable, the funding agency within the department. Federal pass through programs are presented by the entity through which the Foundation received the federal award. Amounts provided to subrecipient from each federal program have been separately identified for additional analysis. These awards are included in total cash basis expenditures.4.The Foundation has a federally negotiated indirect cost rate and therefore elected not to use the 10% de minimis indirect cost rate as covered in 2 CFR ?200.414. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.